Exponent Stock Price, News & Analysis (NASDAQ:EXPO)

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent declared a quarterly dividend on Thursday, July 18th. Stockholders of record on Friday, September 6th will be paid a dividend of $0.16 per share on Friday, September 20th. This represents a $0.64 annualized dividend and a dividend yield of 0.92%. The ex-dividend date is Thursday, September 5th. View Exponent's Dividend History.

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

Exponent, Inc. (NASDAQ:EXPO) issued its earnings results on Thursday, July, 18th. The business services provider reported $0.39 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.33 by $0.06. The business services provider earned $106.50 million during the quarter, compared to analyst estimates of $95.77 million. Exponent had a return on equity of 23.44% and a net margin of 19.64%. Exponent's quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.34 EPS. View Exponent's Earnings History.

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Exponent.

Exponent will be holding an earnings conference call on Thursday, October 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

5 brokers have issued twelve-month target prices for Exponent's shares. Their predictions range from $72.00 to $81.00. On average, they expect Exponent's share price to reach $75.33 in the next twelve months. This suggests a possible upside of 8.3% from the stock's current price. View Analyst Price Targets for Exponent.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Exponent.

Media stories about EXPO stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Exponent earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned media headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Exponent.

Exponent saw a decline in short interest in September. As of September 30th, there was short interest totalling 579,800 shares, a decline of 13.3% from the August 30th total of 668,600 shares. Based on an average daily trading volume, of 290,300 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.1% of the shares of the company are short sold. View Exponent's Current Options Chain.

Some companies that are related to Exponent include Booz Allen Hamilton (BAH), Genpact (G), FTI Consulting (FCN), ICF International (ICFI), RMR Group (RMR), NIC (EGOV), Huron Consulting Group (HURN), Navigant Consulting (NCI), Gopher Protocol (GOPH), Apollo Medical (AMEH), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III) and ATIF (ATIF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include Energy Transfer LP Unit (ET), NetApp (NTAP), Twitter (TWTR), CBL & Associates Properties (CBL), Cornerstone Total Return Fund (CRF), Martin Midstream Partners (MMLP), Micron Technology (MU), AbbVie (ABBV), Ford Motor (F) and Navios Maritime Midstream Partners (NAP).

Exponent's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (1.09%), State of Alaska Department of Revenue (0.08%), Crossmark Global Holdings Inc. (0.01%) and Clarus Wealth Advisors (0.01%). Company insiders that own Exponent stock include Carol Lindstrom, Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Institutional Ownership Trends for Exponent.

EXPO stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Crossmark Global Holdings Inc. and Clarus Wealth Advisors. Company insiders that have sold Exponent company stock in the last year include Carol Lindstrom, Harri Kytomaa, John Pye and Richard L Schlenker Jr. View Insider Buying and Selling for Exponent.

EXPO stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for Exponent.

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EXPO stock can currently be purchased for approximately $69.53.

Exponent has a market capitalization of $3.61 billion and generates $379.52 million in revenue each year. The business services provider earns $72.25 million in net income (profit) each year or $1.25 on an earnings per share basis. Exponent employs 1,122 workers across the globe.View Additional Information About Exponent.

The official website for Exponent is http://www.exponent.com/.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]